Redwood City, CA, United States of America

Giancarlo Garbagnati

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Giancarlo Garbagnati: Innovator in Enzymatic Synthesis of Oligonucleotides

Introduction

Giancarlo Garbagnati is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the enzymatic synthesis of oligonucleotides. His innovative work has implications for various applications in genetic research and molecular biology.

Latest Patents

Garbagnati holds a patent for a "Method and system for enzymatic synthesis of oligonucleotides." This patent describes methods, processes, and systems for synthesizing oligonucleotides from a single-stranded, immobilized primer in the presence of a polymerase. The disclosed methods allow for the enzymatic synthesis of single-stranded oligonucleotides using deoxyribonucleotide triphosphates or ribonucleotide triphosphates. The patent also covers the addition of dideoxyribonucleotide triphosphates and other reversible terminators to the primer or its extension products.

Career Highlights

Garbagnati's career is marked by his work at Centrillion Technology Holdings Corporation, where he has been instrumental in advancing enzymatic synthesis techniques. His expertise in this area has positioned him as a key figure in the biotechnology sector.

Collaborations

Garbagnati has collaborated with notable colleagues, including Kendall Hoff and Michelle Halpain. These partnerships have further enhanced his research and development efforts in the field of oligonucleotide synthesis.

Conclusion

Giancarlo Garbagnati's contributions to the enzymatic synthesis of oligonucleotides represent a significant advancement in biotechnology. His innovative methods and collaborative efforts continue to influence the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…